Trial Combining Pembrolizumab and Cesium 131 Brachytherapy With Salvage Surgery in HNSCC

NCT04340258 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

HNSCC

Interventions

DEVICE: Cesium-131
DRUG: Pembrolizumab

Sponsor

University of Cincinnati

Collaborators

[object Object]